The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study.
Katharine Jane LookerRoss D BootonNajida BegumEkkehard C BeckJing ShenKatherine M E TurnerHannah ChristensenPublished in: BMC public health (2023)
A partially-effective vaccine against gonorrhoea infection, delivered to 14-year-olds alongside the MenACWY vaccine, could have an important population impact on gonorrhoea. Catch-up and booster vaccination could be considered alongside cohort vaccination to increase impact.